Comparative antimicrobial activities of the penem WY-49605 (SUN5555) against recent clinical isolates from five U.S. medical centers.

@article{Sewell1995ComparativeAA,
  title={Comparative antimicrobial activities of the penem WY-49605 (SUN5555) against recent clinical isolates from five U.S. medical centers.},
  author={D. Sewell and A. Barry and S. Allen and P. Fuchs and J. Mclaughlin and M. Pfaller},
  journal={Antimicrobial agents and chemotherapy},
  year={1995},
  volume={39},
  pages={1591 - 1595}
}
The in vitro activity of WY-49605 (SUN5555) (WY) was compared with those of cefaclor, cefixime, and amoxicillin-clavulanic acid against 2,958 consecutive clinical isolates from five medical centers and 402 respiratory pathogens from 18 other facilities. Most members of the family Enterobacteriaceae were inhibited by WY (MIC at which 50% of the isolates are inhibited [MIC50], < or = 2.0 micrograms/ml). MIC90s of > or = 8.0 micrograms/ml were observed for Enterobacter cloacae, Serratia spp., and… Expand
4 Citations

References

SHOWING 1-10 OF 10 REFERENCES
Comparative antibacterial activity of the penem ALP 201.
In-vitro activity of the penem, FCE 22101, and tentative interpretive criteria for disc susceptibility tests.
Penems: In Vitro and In Vivo Experiments
Studies on penem antibiotics. II. In vitro activity of SUN5555, a new oral penem.
Physiologically based pharmacokinetics of a new penem, SUN5555, for evaluation of in vivo efficacy.
  • A. Tsuji, H. Sato, +5 authors T. Noguchi
  • Chemistry, Medicine
  • Drug metabolism and disposition: the biological fate of chemicals
  • 1990
Antibacterial activity and b-lactamases stability of SY5555, a novel oral penem, abstr
  • In Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy
  • 1992
In vitro activity of SY5555, a novel penem, against anaerobic bacteria, abstr
  • In Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy
  • 1992
Comparative antibacterial activity of the penem ALP201. Chemotherapy (Basel) 37:413–419
  • 1991